Bimekizumab Efficacy and Safety Over 48 Weeks in US and Canadian Patients with Psoriasis who had a Treatment Interruption After 3 Years of Treatment: Results from BE RADIANT. J of Skin. 2024;8(6):s431. doi:10.25251/skin.8.supp.431